Abstract

BackgroundRemote ischemic perconditioning (RIPerC) has a promising therapeutic insight to improve the prognosis of acute myocardial infarction. Chronic comorbidities such as diabetes are known to interfere with conditioning interventions by modulating cardioprotective signaling pathways, such as e.g., mTOR pathway and autophagy. However, the effect of acute hyperglycemia on RIPerC has not been studied so far. Therefore, here we investigated the effect of acute hyperglycemia on cardioprotection by RIPerC.MethodsWistar rats were divided into normoglycemic (NG) and acute hyperglycemic (AHG) groups. Acute hyperglycemia was induced by glucose infusion to maintain a serum glucose concentration of 15–20 mM throughout the experimental protocol. NG rats received mannitol infusion of an equal osmolarity. Both groups were subdivided into an ischemic (Isch) and a RIPerC group. Each group underwent reversible occlusion of the left anterior descending coronary artery (LAD) for 40 min in the presence or absence of acute hyperglycemia. After the 10-min LAD occlusion, RIPerC was induced by 3 cycles of 5-min unilateral femoral artery and vein occlusion and 5-min reperfusion. After 120 min of reperfusion, infarct size was measured by triphenyltetrazolium chloride staining. To study underlying signaling mechanisms, hearts were harvested for immunoblotting after 35 min in both the NG and AHG groups.ResultsInfarct size was significantly reduced by RIPerC in NG, but not in the AHG group (NG + Isch: 46.27 ± 5.31 % vs. NG + RIPerC: 24.65 ± 7.45 %, p < 0.05; AHG + Isch: 54.19 ± 4.07 % vs. 52.76 ± 3.80 %). Acute hyperglycemia per se did not influence infarct size, but significantly increased the incidence and duration of arrhythmias. Acute hyperglycemia activated mechanistic target of rapamycine (mTOR) pathway, as it significantly increased the phosphorylation of mTOR and S6 proteins and the phosphorylation of AKT. In spite of a decreased LC3II/LC3I ratio, other markers of autophagy, such as ATG7, ULK1 phopsphorylation, Beclin 1 and SQSTM1/p62, were not modulated by acute hyperglycemia. Furthermore, acute hyperglycemia significantly elevated nitrative stress in the heart (0.87 ± 0.01 vs. 0.50 ± 0.04 µg 3-nitrotyrosine/mg protein, p < 0.05).ConclusionsThis is the first demonstration that acute hypreglycemia deteriorates cardioprotection by RIPerC. The mechanism of this phenomenon may involve an acute hyperglycemia-induced increase in nitrative stress and activation of the mTOR pathway.

Highlights

  • Remote ischemic perconditioning (RIPerC) has a promising therapeutic insight to improve the prog‐ nosis of acute myocardial infarction

  • We have shown that acute hyperglycemia increased nitrative stress and activated cardiac mechanistic target of rapamycine pathway, but not cardiac autophagy, which might be involved in the mechanism of the lost cardioprotection by RIPerC in acute hyperglycemia

  • Acute hyperglycemia abolishes the protective effect of RIPerC To investigate the effect of acute hyperglycemia on the efficacy of RIPerC, acute hyperglycemia was induced with a 50 % dextrose infusion during in vivo ischemia/ reperfusion experiments

Read more

Summary

Introduction

Remote ischemic perconditioning (RIPerC) has a promising therapeutic insight to improve the prog‐ nosis of acute myocardial infarction Chronic comorbidities such as diabetes are known to interfere with condition‐ ing interventions by modulating cardioprotective signaling pathways, such as e.g., mTOR pathway and autophagy. The largest randomized multi-center clinical trial including 1612 patients [Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA)] did not show any benefit on major adverse cardiac and cerebral events [5]. Reasons of these discrepancies are yet to be determined

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call